| Age group (years) | |||||
---|---|---|---|---|---|---|
 | 0 - <2 | 2 - 4 | 5 - 17 | 18 - 49 | 50 - 64 | 65+ |
Annual Incidence per 100,000 | Â | Â | Â | Â | Â | Â |
   Pneumococcal meningitis/a | 9.1 | 1.1 | 2.3 | 0.5 | 1.5 | 1.7 |
   Pneumococcal bacteremia/a | 174.8 | 35.8 | 3.8 | 12.3 | 22.7 | 58.8 |
   All-cause pneumonia/b | 4,710 | 1,517 | 329 | 383 | 1,462 | 9,294 |
   All-cause otitis media (per person)/c | 1.10 | 0.58 |  |  |  |  |
Case Fatality Rates | Â | Â | Â | Â | Â | Â |
   Pneumococcal meningitis/d | 0.05 | 0.05 | 0.04 | 0.13 | 0.21 | 0.27 |
   Pneumococcal bacteremia/d | 0.01 | 0.01 | 0.02 | 0.08 | 0.12 | 0.16 |
   All-cause pneumonia/e | 0.00 | 0.02 | 0.02 | 0.02 | 0.05 | 0.05 |
Proportion meningitis cases resulting in (%) | Â | Â | Â | Â | Â | Â |
   Deafness/f | 13.0 | 13.0 | 6.4 | 13.0 | 13.0 | 13.0 |
   Disability/f | 6.7 | 6.7 | 5.2 | 6.7 | 6.7 | 6.7 |
Vaccine Effectiveness | Â | Â | Â | Â | Â | Â |
   IPD |  |  |  |  |  |  |
Efficacy/g | 73.5% | 67.0% | Â | Â | Â | Â |
Indirect (herd) effect/h | 46.8% | 40.3% | 17.5% | 38.3% | 17.4% | 33.6% |
   All-cause pneumonia |  |  |  |  |  |  |
Efficacy/i | 6.9% | 6.3% | Â | Â | Â | Â |
Indirect (herd) effect/j | 17.6% | 18.9% | 9.0% | 13.0% | 9.3% | 7.7% |
   All-cause otitis media |  |  |  |  |  |  |
Efficacy/i | 6.4% | 5.8% | Â | Â | Â | Â |
Indirect (herd) effect/k | 20.1% | 19.0% | Â | Â | Â | Â |
Costs ($) per Case of Pneumococcal Disease | Â | Â | Â | Â | Â | Â |
   Meningitis/l | 13,196 | 13,196 | 7,446 | 10,586 | 13,461 | 10,263 |
Deafness/m | 101,975 | 101,387 | 97,679 | 82,278 | 57,428 | 31,733 |
Disability/m | 526,174 | 523,143 | 504,006 | 424,543 | 296,317 | 163,738 |
   Bacteremia/l | 2,754 | 2,754 | 7,446 | 10,586 | 13,461 | 10,263 |
   Pneumonia/n | 592 | 592 | 5,166 | 6,465 | 7,558 | 7,263 |
   Otitis media/o | 256 | 256 |  |  |  |  |